Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies

Obesity is reaching epidemic proportions with recent worldwide figures estimated at 1.4 billion and rising year‐on‐year. Obesity affects all socioeconomic backgrounds and ethnicities and is a pre‐requisite for metabolic syndrome. Metabolic syndrome is a clustering of risk factors, such as central obesity, insulin resistance, dyslipidaemia and hypertension that together culminate in the increased risk of type 2 diabetes mellitus and cardiovascular disease. As these conditions are among the leading causes of deaths worldwide and metabolic syndrome increases the risk of type 2 diabetes mellitus fivefold and cardiovascular disease threefold, it is of critical importance that a precise definition is agreed upon by all interested parties. Also of particular interest is the relationship between metabolic syndrome and cancer. Metabolic syndrome has been associated with a plethora of cancers including breast, pancreatic, colon and liver cancer. Furthermore, each individual risk factor for metabolic syndrome has also an association with cancer. Our review collates internationally generated information on metabolic syndrome, its many definitions and its associations with life‐threatening conditions including type 2 diabetes mellitus, cardiovascular disease and cancer, providing a foundation for future advancements on this topic.

[1]  J. Herrera Acosta.  [Insulin resistance and hypertension]. , 1994, Gaceta medica de Mexico.

[2]  D. Mikhailidis,et al.  Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population , 2010, Current medical research and opinion.

[3]  G. Kolovou,et al.  Pathophysiology of dyslipidaemia in the metabolic syndrome , 2005, Postgraduate Medical Journal.

[4]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[5]  Yan V. Sun,et al.  A Bivariate Genome-Wide Approach to Metabolic Syndrome , 2011, Diabetes.

[6]  K. Reynolds,et al.  Update on the metabolic syndrome: Hypertension , 2009, Current hypertension reports.

[7]  D. Balding,et al.  A Genome-Wide Association Study of the Metabolic Syndrome in Indian Asian Men , 2010, PloS one.

[8]  C. Hutter,et al.  Genome‐wide Linkage Scan for the Metabolic Syndrome: The GENNID Study , 2008, Obesity.

[9]  D. Leroith,et al.  The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms , 2010 .

[10]  P. Zimmet,et al.  Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. , 2004, Diabetes research and clinical practice.

[11]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[12]  R. Hegele,et al.  Genetics of metabolic syndrome , 2008, Current diabetes reports.

[13]  Insulin resistance as an independent risk factor for cardiovascular disease : clinical assessment and therapy approaches , 2009 .

[14]  J. Shaw,et al.  Mainstreaming the metabolic syndrome: a definitive definition , 2005, The Medical journal of Australia.

[15]  I. Rudan,et al.  Genome-wide association study of anthropometric traits in Korcula Island, Croatia. , 2009, Croatian medical journal.

[16]  Ronald Klein,et al.  Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. , 2002, Diabetes care.

[17]  Richard A. Johnson.  Trends in the Prevalence and Ratio of Diagnosed to Undiagnosed Diabetes According to Obesity Levels in the U.S., EW Gregg, BL Cadwell, YJ Cheng, in: Diabetes Care., 27. (2004), 2806 , 2008 .

[18]  D. Leroith,et al.  Epidemiology and Molecular Mechanisms Tying Obesity, Diabetes, and the Metabolic Syndrome With Cancer , 2013, Diabetes Care.

[19]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[20]  G. Di Fede,et al.  "The Linosa Study": epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[21]  Zhongjie Sun,et al.  Current views on type 2 diabetes. , 2010, Journal of Endocrinology.

[22]  Subhajyoti De,et al.  Common variants near MC4R are associated with fat mass, weight and risk of obesity , 2008, Nature Genetics.

[23]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[24]  M. Boaz,et al.  Low HDL levels and the risk of death, sepsis and malignancy , 2008, Clinical Research in Cardiology.

[25]  Swarup A. V. Shah,et al.  Prevalence of Metabolic Syndrome in Urban India , 2011, Cholesterol.

[26]  K. Münstedt,et al.  Effect of obesity on survival in epithelial ovarian cancer , 2007, Cancer.

[27]  J. Weber,et al.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Rotella,et al.  Cardio Vascular Diabetology Open Access Original Investigation , 2022 .

[29]  Jaspinder Kaur.  A Comprehensive Review on Metabolic Syndrome , 2014, Cardiology research and practice.

[30]  J. Després,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[31]  D. D’Alessio,et al.  The role of dysregulated glucagon secretion in type 2 diabetes , 2011, Diabetes, obesity & metabolism.

[32]  E. Tai,et al.  Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome? , 2007, Diabetes Care.

[33]  C. Hoggart,et al.  Genome-wide association analysis of metabolic traits in a birth cohort from a founder population , 2008, Nature Genetics.

[34]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[35]  S. Dang,et al.  Prevalence and Determinants of Metabolic Syndrome among Adults in a Rural Area of Northwest China , 2014, PloS one.

[36]  G. Reaven.  Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease , 2002, Circulation.

[37]  B. Howard,et al.  Dyslipidemia of the metabolic syndrome , 2002, Current cardiology reports.

[38]  C. Farber,et al.  Glucagon regulates hepatic kisspeptin to impair insulin secretion. , 2014, Cell metabolism.

[39]  Leonid Poretsky.  Principles of Diabetes Mellitus , 2017 .

[40]  D. O'Shea,et al.  An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population , 2009, Irish journal of medical science.

[41]  Eric Boerwinkle,et al.  The Atherosclerosis Risk in Communities (ARIC) Study , 2011 .

[42]  B. Egan,et al.  Insulin resistance and cardiovascular disease. , 2001, American journal of hypertension.

[43]  Antonio Brunetti,et al.  Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms , 2012, Experimental diabetes research.

[44]  G. Reaven.  Banting lecture 1988 , 1997 .

[45]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[46]  C. Morrison,et al.  Waist circumference as a measure for indicating need for weight management , 1995, BMJ.

[47]  Christian Gieger,et al.  Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.

[48]  R. Sacco,et al.  Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study , 2005, Diabetologia.

[49]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[50]  D. Leroith,et al.  The Link between the Metabolic Syndrome and Cancer , 2011, International journal of biological sciences.

[51]  M. Brady.  IRS2 takes center stage in the development of type 2 diabetes. , 2004, The Journal of clinical investigation.

[52]  H. Lebovitz,et al.  Type 2 diabetes: an overview. , 1999, Clinical chemistry.

[53]  S. Pal,et al.  The Chronic Effects of Whey Proteins on Blood Pressure, Vascular Function, and Inflammatory Markers in Overweight Individuals , 2010, Obesity.

[54]  A. Folsom,et al.  HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study. , 2008, Lung cancer.

[55]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[56]  R Bethene Ervin,et al.  Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. , 2009, National health statistics reports.

[57]  J. Shaw,et al.  The metabolic syndrome in Australia: prevalence using four definitions. , 2007, Diabetes research and clinical practice.

[58]  Sung Hee Choi,et al.  Increasing Prevalence of Metabolic Syndrome in Korea , 2011, Diabetes Care.

[59]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.

[60]  T. Hansen,et al.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. , 2007, Journal of the American College of Cardiology.

[61]  Subhashini Yaturu,et al.  Metabolic syndrome and cancer. , 2009, Metabolic syndrome and related disorders.

[62]  Gary K. Chen,et al.  Meta-analysis identifies common variants associated with body mass index in East Asians , 2012, Nature Genetics.

[63]  S. Sookoian,et al.  Metabolic Syndrome: From the Genetics to the Pathophysiology , 2011, Current hypertension reports.

[64]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[65]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[66]  V. Mohan,et al.  Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES‐34) , 2007, Diabetes/metabolism research and reviews.

[67]  Talicia Tarver,et al.  HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .

[68]  R. D'Agostino,et al.  Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.

[69]  P. Deedwania,et al.  Management issues in the metabolic syndrome. , 2006, The Journal of the Association of Physicians of India.

[70]  Jing Chen,et al.  Prevalence of the metabolic syndrome and overweight among adults in China , 2005, The Lancet.

[71]  R. Krauss,et al.  Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population , 1980, Lipids.

[72]  P. Zimmet,et al.  The metabolic syndrome: Time to reflect , 2006, Current diabetes reports.

[73]  G. Liguori,et al.  Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006 , 2010, Diabetes Care.

[74]  Betsy L Cadwell,et al.  Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. , 2004, Diabetes care.

[75]  C. Barnes,et al.  Genome-Wide Screen for Metabolic Syndrome Susceptibility Loci Reveals Strong Lipid Gene Contribution But No Evidence for Common Genetic Basis for Clustering of Metabolic Syndrome Traits , 2012, Circulation. Cardiovascular genetics.

[76]  E. Ford,et al.  Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. , 2005, Diabetes care.

[77]  L. Duvnjak.  Hypertension and the Metabolic Syndrome , 2007, EJIFCC.

[78]  C. Bouchard,et al.  Genome-wide linkage scan for the metabolic syndrome in the HERITAGE Family Study. , 2003, The Journal of clinical endocrinology and metabolism.

[79]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.